In a regulatory filing, the company stated: “On October 14, 2025, DENTSPLY SIRONA (XRAY) announced that the Division of Enforcement of the Securities and Exchange Commission has concluded its investigation of the Company commenced in May 2022 and does not intend to recommend any enforcement action against the Company. The SEC Investigation related to the Company’s investigation led by the Audit and Finance Committee, initiated in March 2022, into allegations regarding certain financial reporting matters submitted by current and former employees of the Company. As previously disclosed, the Company voluntarily contacted the SEC regarding these matters and has fully cooperated with the SEC throughout the course of the SEC Investigation. The Company views the closure without any enforcement action as a significant and favorable development.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- DENTSPLY SIRONA SEC Investigation Concludes Favorably
- Dentsply Sirona price target lowered to $13 from $17 at Evercore ISI
- DENTSPLY SIRONA Announces Leadership Transition for Rosenzweig
- Dentsply Sirona appoints Denti as Chief Commercial Officer
- Cautious Hold Rating on DENTSPLY SIRONA Amid Awaited Turnaround Evidence